The company has plans to launch this Vaccine by the end of 2023 after completing the required field studies and obtaining regulatory approvals
J. B. Chemicals & Pharmaceuticals has informed that the acquisition of the Razel franchise from Glenmark Pharmaceuticals Limited has been successfully completed.
This combination has the potential to be the first treatment option combining an antibody-drug conjugate plus an immunotherapy in this treatment setting
Results demonstrated a 64.5% confirmed objective response rate in patients treated with investigational combination of enfortumab vedotin and pembrolizumab
MeitY will provide technical support for digitalisation of the Ayush Sector under the Ayush Grid project for a period of three years
Lung cancer is the leading cause of cancer death in the USA, making up almost 25% of all cancer deaths
It paves the way for an industry Code of Good Practice
Achieving ML 4 brings Singapore closer to becoming a WHO listed authority, a new scheme that will be operational later this year and will list the world’s regulators of reference
The partnership is already underway having launched earlier last week, and the contract could be worth up to £211 million.
Singapore Health Sciences Authority (HSA) approval marks the first in a series of expected approvals of trodelvy in Asia
Subscribe To Our Newsletter & Stay Updated
